This website uses cookies to ensure you get the best experience. Learn more

PrEP Will Be Given for Free to 200,000 Americans for 11 Years

Pharmaceutical corporation Gilead have announced a deal with the Trump administration to provide 200,000 people in the US with free access to the PrEP drug Truvada for eleven years.

 

If taken daily, PrEP significantly reduces the chances of an HIV-infection. Countries that have introduced PrEP have seen a dramatic reduction in new cases of HIV.